Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes
- PMID: 28249135
- DOI: 10.1056/NEJMc1615712
Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes
Comment on
-
Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes.N Engl J Med. 2017 Mar 2;376(9):891. doi: 10.1056/NEJMc1615712. N Engl J Med. 2017. PMID: 28249136 No abstract available.
-
Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes.N Engl J Med. 2017 Mar 2;376(9):890. doi: 10.1056/NEJMc1615712. N Engl J Med. 2017. PMID: 28252261 No abstract available.
-
Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes.N Engl J Med. 2017 Mar 2;376(9):890-1. doi: 10.1056/NEJMc1615712. N Engl J Med. 2017. PMID: 28252263 No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical